Neurological disorders Archives

Latest Posts

News and Trends 13 Jul 2015

After being rejected twice, Horizon pushes Depomed to accept its €2.7Bn offer

Horizon Pharma is getting anxious and has offered the substantial amount of €2.7Bn to buy its American competitor Depomed. The Irish drug-maker plans to add the US-based firm to its shopping list just after enrolling Hyperion Therapeutics, the company that was purchased only one month ago. Dublin-based Horizon has been pursuing Depomed lately, but the American company is playing […]

July 13, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 10 Jul 2015

First-in-human successful Phase I for an Alzheimer’s vaccine

AXON Neuroscience has completed a pioneer Phase I that offers new hope for millions of patients with Alzheimer’s disease. This makes AXON the first company to successfully complete this clinical trial for a vaccine that targets diseased tau proteins, which cause neural degeneration. Alzheimer’s disease is characterized by the presence of prejudicial forms of protein […]

July 10, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 2 Jul 2015

Roche and Evotec knocked down by their Alzheimer candidate

The progressive aging of the population in developed countries is turning Alzheimer into one of the biggest medical challenges of our times. And it looks like it is going to remain an unresolved problem for the moment, as Roche’s candidate failed its last clinical trial. The drug, developed in collaboration with German Evotec, didn’t meet […]

July 2, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 4 Mar 2015

Alkermes presents its new treatment of Alzheimer’s agitation

Alkermes reveals a new drug candidate, ALKS 7119, for treatment of Alzheimer’s agitation, depression and other central nervous system (CNS) diseases. Alkermes has successfully completed preclinical development and expects to initiate the first clinical study of its newest candidate, ALKS 7119, in the third quarter of 2015. ALKS 7119 has a multivalent mechanism of action […]

March 4, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 18 Feb 2015

#BioFigures: 3,000 whole genomes sequenced to fight Parkinson!

WHO? 23andMe, founded in 2006, is the leading personal genetics company dedicated to helping people access, understand and benefit from the human genome. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. Photo credit: 23andMe WHAT? 23andMe, announced an agreement with Genentech, a member of the Swiss Roche Group, […]

February 18, 2015 - 2 minutesmins - By Marie Godar

News and Trends 11 Feb 2015

AB Science: One step further towards a cure to Alzheimer’s disease

AB Science SA, a pharmaceutical company specialized in research, development and marketing of protein kinase inhibitors (PKIs), today announced the successful completion of a futility analysis related to the masitinib phase 3 trial for the treatment of mild to moderate Alzheimer’s disease. Today, between 5 and 10 million people suffer from Alzheimer’s disease in the USA […]

February 11, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 21 Aug 2014

Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells

Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal stem cells (itMSCs) in a pre-clinical animal model of Alzheimer’s disease. The results demonstrated a greater than 30% decrease in amyloid beta (Abeta) plaques in […]

August 21, 2014 - 2 minutesmins - By Joachim Eeckhout

Resources

Categories

Swiss biotech going strong in 2024: 18 companies to put on your radar

The ABC of biotech startup funding

Approaches

Therapeutic areas

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Special Olympics: How is biotechnology revolutionizing sports performance worldwide?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us